REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 67 filers reported holding REPARE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,822,000 | -46.4% | 221,879 | -36.3% | 0.35% | -40.2% |
| Q2 2021 | $10,859,000 | +9.2% | 348,279 | +7.5% | 0.59% | +32.9% |
| Q1 2021 | $9,946,000 | +3.2% | 324,079 | +15.3% | 0.44% | -35.2% |
| Q4 2020 | $9,638,000 | +55.2% | 280,979 | +39.3% | 0.68% | +53.2% |
| Q3 2020 | $6,209,000 | – | 201,779 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |